Development and Validation of a Daily Pain Catastrophizing Scale

Stanford University

Status: Completed

Conditions: Chronic Pain

Treatments: Behavioral: Questionnaires

Study type: Observational

Funder types: Other

Identifiers

NCT02778555

R01AT008561-01A1

Details and patient eligibility

About

This study sought to develop and validate a brief, daily version of the Pain Catastrophizing Scale.

Full description

The Pain Catastrophizing Scale (PCS; 13 items; factors: rumination, helplessness, magnification) (Sullivan 1995) measures trait catastrophizing in the context of actual or anticipated pain. Currently, there is no validated tool for measuring pain catastrophizing at the daily level. Lack of a validated daily measure stands as a barrier for studies that aim to characterize mechanisms of pain treatment and how PC adaptation / change occurs.

Enrollment: 713 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Age 18 or above
2. Chronic pain of any etiology
3. Online access
4. Ability to participate in daily measurements over 14 days

Exclusion criteria

1. Lack of ability to answer questionnaires and daily catastrophizing captures, at the discretion of study staff.

Trial design

713 participants in 3 patient groups

Sample 1

Description:

In Sample 1 (N=186), our 14-item Daily PCS was administered daily for 14 days to replicate the 3-factor structure at the daily level, and to select the ideal 5 items for a brief Daily PCS.

Treatment:

Behavioral: Questionnaires

Sample 2

Description:

In Sample 2 (N=209), the 5-item Daily PCS was administered daily for 14 days with short forms for PROMIS Pain Intensity, Depression, Anger, and Anxiety included on days 1, 7, and 14.

Treatment:

Behavioral: Questionnaires

Sample 3

Description:

In Sample 3 (N=318), the 5-item Daily PCS was administered daily for 14 days with short forms for PROMIS Pain Intensity, Depression, Anger, and Anxiety included on days 1, 7, and 14. In addition, assessments of pain, mood, activity, sleep, energy level, and positive affect were administered daily for the 14-day period.

Treatment:

Behavioral: Questionnaires